Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Open Label Use of the Hi-OXSR to Increase PaCO2 for the Treatment of Post COVID-19 Cognitive Dysfunction

NCT06379620 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT06379620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06379620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Open Label Use of the Hi-OXSR to Increase PaCO2 for the Treatment of Post COVID-19 Cognitive Dysfunction
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Completed
Start date
November 29, 2022
Completion date
March 4, 2024
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post covid-19 condition